The key role of ASCT2 to sustain cancer cell metabolism has been demonstrated by silencing ASCT2 in different cell lines, with the consequent reduction of both cell viability and of downstream glutamine-linked pathways [9,61,113,153,154,155]. The gene discussed is SLC1A5; the disease is cancer.